SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company's management will participate in a fireside chat and scheduled one-on-one investor meetings at the JMP Securities Hematology and Oncology Summit, to be held virtually December 5–6, 2023.
Format: Fireside chat and scheduled one-on-one investor meetings
Date: Wednesday, December 6, 2023
Time: 1:00 p.m. ET
Location: Virtual
Webcast Link: Click Here
About BioAtla, Inc.
BioAtla is a global clinical-stage biotechnology company with operations in San Diego, ...